Patents by Inventor Richard Guertin

Richard Guertin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Adamantyl-pyrazole carboxamides as inhibitors of 11B-hydroxysteroid dehydrogenase
    Publication number: 20070225280
    Abstract: Provided herein are compounds of the formula (I): as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of diseases such as, for example, type II diabetes mellitus and metabolic syndrome.
    Type: Application
    Filed: March 14, 2007
    Publication date: September 27, 2007
    Inventors: Kevin William Anderson, Nader Fotouhi, Paul Gillespie, Robert Alan Goodnow, Kevin Richard Guertin, Nancy-Ellen Haynes, Michael Paul Myers, Sherrie Lynn Pietranico-Cole, Lida Qi, Pamela Loreen Rossman, Nathan Robert Scott, Kshitij Chhabilbhai Thakkar, Jefferson Wright Tilley, Qiang Zhang
  • Cleaner for cooling system screen of outdoor power equipment unit
    Publication number: 20070022720
    Abstract: A screen cleaner for an outdoor power equipment unit comprises a cleaning member pivotally mounted adjacent a screen in the cooling system for the prime mover of the outdoor power equipment unit. A reversible powered actuator oscillates the screen cleaner back and forth over the screen to momentarily block air flow through the portion of the screen covered by the cleaning member. Any airborne debris such as grass clippings adhering to the portion of the screen covered by the cleaning member will fall off the screen during the time the air flow is momentarily blocked by the cleaning member. The screen is slanted inwardly as it extends downwardly to enhance the ability of the debris to fall off the screen without sticking to lower portions of the screen.
    Type: Application
    Filed: July 27, 2005
    Publication date: February 1, 2007
    Inventor: Richard Guertin
  • Substituted 3-cyanothiophene acetamides as glucagon receptor antagonists
    Patent number: 7138529
    Abstract: The present invention relates to compounds of formula (I) wherein R1, R2, R3, R4 and n are as defined in the description and claims, and pharmaceutically acceptable salts thereof. The compounds are useful for the treatment and/or prophylaxis of diseases which are associated with the antagonism of the glucagon receptor, such as diabetes.
    Type: Grant
    Filed: April 8, 2004
    Date of Patent: November 21, 2006
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Shawn David Erickson, Paul Gillespie, Kevin Richard Guertin
  • 5-substituted-six-membered heteroaromatic glucokinase activators
    Patent number: 7132425
    Abstract: The present invention provides a compound according to formula I where the substituent designations are provided in the specification. Pharmaceutical compositions comprising a compound according to formula I are also provided.
    Type: Grant
    Filed: December 10, 2003
    Date of Patent: November 7, 2006
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Shaoqing Chen, Wendy Lea Corbett, Kevin Richard Guertin, Nancy-Ellen Haynes, Robert Francis Kester, Francis A. Mennona, Steven Gregory Mischke, Yimin Qian, Ramakanth Sarabu, Nathan Robert Scott, Kshitij Chhabilbhai Thakkar
  • Novel substituted 3-cyanothiophene acetamides as glucagon receptor antagonists
    Publication number: 20040209943
    Abstract: The present invention relates to compounds of formula (I) 1
    Type: Application
    Filed: April 8, 2004
    Publication date: October 21, 2004
    Inventors: Shawn David Erickson, Paul Gillespie, Kevin Richard Guertin
  • 5-Substituted-six-membered heteroaromatic glucokinase activators
    Publication number: 20040147748
    Abstract: The present invention provides a compound according to formula I 1
    Type: Application
    Filed: December 10, 2003
    Publication date: July 29, 2004
    Inventors: Shaoqing Chen, Wendy Lea Corbett, Kevin Richard Guertin, Nancy-Ellen Haynes, Robert Francis Kester, Francis A. Mennona, Steven Gregory Mischke, Yimin Qian, Ramakanth Sarabu, Nathan Robert Scott, Kshitij Chhabilbhai Thakkar
  • Pyrimido[5,4-e][1,2,4]triazine-5,7-diamine compounds as protein tyrosine phosphatase inhibitors
    Patent number: 6642381
    Abstract: The invention relates to pyrimido[5,4-e][1,2,4]triazine-5,7-diamine compounds which are useful for inhibiting protein tyrosine phosphatases, particularly PTP1B.
    Type: Grant
    Filed: December 10, 2002
    Date of Patent: November 4, 2003
    Assignee: Hoffman-La Roche Inc.
    Inventors: Kevin Richard Guertin, Lina Quattrocchio Setti
  • Pyrimido[5,4-e] [1,2,4]triazine-5, 7-diamine compounds as protein tyrosine phosphatase inhibitors
    Publication number: 20030153756
    Abstract: The invention relates to pyrimido[5,4-e][1,2,4]triazine-5,7-diamine compounds which are useful for inhibiting protein tyrosine phosphatases, particularly PTP1B.
    Type: Application
    Filed: December 10, 2002
    Publication date: August 14, 2003
    Inventors: Kevin Richard Guertin, Lina Quattrocchio Setti
  • Isoindolin-1-one glucokinase activators
    Patent number: 6482951
    Abstract: Isoindolin-1-one-substituted propionamide glucokinase activators which increase insulin secretion in the treatment of type II diabetes.
    Type: Grant
    Filed: December 6, 2001
    Date of Patent: November 19, 2002
    Assignee: Hoffmann-La Roche Inc.
    Inventor: Kevin Richard Guertin
  • Isoindolin-1-one glucokinase activators
    Publication number: 20020082260
    Abstract: Isoindolin-1-one-substituted propionamide glucokinase activators which increase insulin secretion in the treatment of type II diabetes.
    Type: Application
    Filed: December 6, 2001
    Publication date: June 27, 2002
    Inventor: Kevin Richard Guertin